Equities

Regencell Bioscience Holdings Ltd

RGC:NAQ

Regencell Bioscience Holdings Ltd

Actions
  • Price (USD)5.27
  • Today's Change0.00 / 0.00%
  • Shares traded103.00
  • 1 Year change-80.56%
  • Beta--
Data delayed at least 15 minutes, as of Apr 30 2024 20:51 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

  • Revenue in USD (TTM)0.00
  • Net income in USD-7.45m
  • Incorporated2014
  • Employees12.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Celularity Inc14.79m-181.41m65.78m225.00--1.93--4.45-10.51-10.510.83761.560.04982.292.0365,724.45-61.05---82.37--21.19---1,226.72--0.136618.400.5365---15.75--114.18------
Benitec Biopharma Inc61.00k-21.81m65.90m18.00--1.32--1,080.30-10.90-10.900.03045.970.0037--1.013,388.89-131.16-83.43-174.32-98.77172.1396.86-35,754.10-468.04---5,423.000.00--2.74-53.84-7.44---56.51--
Champions Oncology Inc49.22m-9.73m66.07m230.00------1.34-0.7183-0.71833.64-0.15141.56--6.17214,017.40-30.91-5.40-96.45-11.8840.0947.96-19.76-3.09--------9.6921.63-1,073.54--18.50--
Annovis Bio Inc0.00-56.20m67.28m6.00---------6.12-6.120.00-0.73680.00----0.00-243.15-106.31-328.17-124.71-----------4.03---------121.90------
Carisma Therapeutics Inc10.63m-73.50m67.71m17.00--1.42--6.37-3.70-3.700.4111.150.0694----625,294.10-47.96-25.47-56.78-27.87-----691.39-236.32----0.0211--50.69148.16-5,817.86------
Tiziana Life Sciences Ltd - ADR0.00-15.40m67.75m9.00--3.46-----0.1496-0.14960.000.19140.00----0.00-40.89---50.40-------------2,083.710.0183------34.25------
enVVeno Medical Corp0.00-23.52m68.32m31.00--1.48-----1.96-1.960.003.470.00----0.00-52.09-58.43-53.82-62.76-------260,799.30----0.00------4.67--21.58--
Regencell Bioscience Holdings Ltd0.00-7.45m68.58m12.00--4.02-----0.5863-0.58630.001.310.00----0.00-82.73---113.11--------------0.00------21.15------
Elutia Inc24.75m-41.25m69.40m54.00------2.80-2.20-2.081.35-1.660.44081.974.90458,240.80-73.48-42.93-309.94-79.3444.6743.32-166.70-64.160.6367-3.54-----49.69-8.71-25.39--12.74--
Landos Biopharma Inc0.00-21.94m69.68m19.00--2.19-----3.49-3.490.0010.200.00----0.00-52.67-59.84-61.86-72.15-------795.80---516.520.00------44.15------
Instil Bio Inc0.00-156.09m69.72m49.00--0.3087-----24.00-24.000.0034.720.00----0.00-38.65---40.84--------------0.265------30.06------
Aileron Therapeutics Inc0.00-15.73m70.61m15.00--2.95-----3.39-3.390.0020.120.00----0.00-24.58-65.99-26.17-75.37------------0.00------42.43------
VolitionRX Ltd775.30k-35.32m71.07m110.00------91.67-0.504-0.5040.0109-0.09530.0335--4.927,048.18-154.29-111.92---196.20-----4,601.71-10,793.31---280.52----153.04---16.68--29.13--
AN2 Therapeutics Inc0.00-64.73m71.45m41.00--0.5724-----2.82-2.820.004.190.00----0.00-53.65---58.83--------------0.00-------51.33------
Data as of Apr 30 2024. Currency figures normalised to Regencell Bioscience Holdings Ltd's reporting currency: US Dollar USD

Institutional shareholders

0.13%Per cent of shares held by top holders
HolderShares% Held
UBS Securities LLCas of 31 Dec 202316.05k0.12%
BlackRock Financial Management, Inc.as of 31 Dec 2023238.000.00%
Qube Research & Technologies Ltd.as of 31 Dec 202313.000.00%
Tower Research Capital LLCas of 31 Dec 20230.000.00%
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 20230.000.00%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.